Alendronate reduces risk of vertebral and clinical fractures in women with existing vertebral fractures: Results of the fracture intervention trial.

被引：0
|
作者：
Black, DM
Cummings, SR
Thompson, D
机构：
[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143
[2] MERCK RES LABS,RAHWAY,NJ
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1996年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：P242 / P242
页数：1
相关论文
共 50 条
  • [21] BAZEDOXIFENE REDUCES ALL CLINICAL FRACTURES AND MORPHOMETRIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN AT INCREASED FRACTURE RISK ASSESSED WITH FRAX®
    McCloskey, E.
    Johansson, H.
    Oden, A.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 16 - 17
  • [22] Treatment with alendronate prevents fractures in women at highest risk - Results from the fracture intervention trial
    Ensrud, KE
    Black, DM
    Palermo, L
    Bauer, DC
    BarrettConnor, E
    Quandt, SA
    Thompson, DE
    Karpf, DB
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (22) : 2617 - 2624
  • [23] Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women with multiple prevalent vertebral fractures
    Ortolani, S
    Fechtenbaum, J
    Devogelaer, J
    Cannata, J
    Bonidan, O
    Hensen, J
    Roux, C
    Meunier, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 93 - 93
  • [24] Natural History and Risk Factors for Adjacent Vertebral Fractures in the Fracture Intervention Trial
    Frankel, Bruce
    Krishna, Vibhor
    Vandergrift, Alex
    Bauer, Douglas C.
    Nicholas, Joyce
    SPINE, 2013, 38 (25) : 2201 - 2207
  • [25] Risedronate rapidly and consistently reduces risk of further vertebral fracture in women with multiple prevalent vertebral fractures.
    Brown, JP
    Hosking, D
    Josse, R
    Johnell, O
    Leib, E
    Roux, C
    Stracke, H
    Bos, K
    Horlait, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S150 - S150
  • [26] Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial
    Hagino, Hiroshi
    Shiraki, Masataka
    Fukunaga, Masao
    Nakano, Tetsuo
    Takaoka, Kunio
    Ohashi, Yasuo
    Nakamura, Toshitaka
    Matsumoto, Toshio
    JOURNAL OF BONE AND MINERAL METABOLISM, 2013, 31 (05) : 544 - 550
  • [27] Number and severity of prevalent vertebral fractures and the risk of subsequent vertebral fractures in Japanese women with osteoporosis: results from the minodronate trial
    Hiroshi Hagino
    Masataka Shiraki
    Masao Fukunaga
    Tetsuo Nakano
    Kunio Takaoka
    Yasuo Ohashi
    Toshitaka Nakamura
    Toshio Matsumoto
    Journal of Bone and Mineral Metabolism, 2013, 31 : 544 - 550
  • [28] Alendronate reduces the risk of clinical vertebral fracture osteopenic women: Data from FIT
    Quandt, S
    Thompson, D
    Schnieder, D
    Nevitt, M
    Musliner, T
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2001, 10 (04): : 406 - 406
  • [29] Alendronate reduces the risk of clinical vertebral fracture in osteopenic women: Data from FIT
    Quandt, S
    Thompson, D
    Schnieder, D
    Nevitt, M
    Musliner, T
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 25 - 25
  • [30] Alendronate reduces the risk of clinical vertebral fracture in osteopenic women: Data from fit
    Quandt, SA
    Thompson, DE
    Schnieder, D
    Nevitt, M
    Musliner, T
    BONE, 2001, 28 (05) : S229 - S229
12345